# Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia

> **NCT00186797** · NA · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 28 (—)

## Conditions studied

- Aplastic Anemia

## Interventions

- **PROCEDURE:** Allogeneic stem cell transplant
- **DRUG:** Fludarabine, Cyclophosphamide

## Key facts

- **NCT ID:** NCT00186797
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2005-09
- **Final completion:** 2007-05
- **Target enrollment:** 28 (—)
- **Last updated:** 2010-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00186797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00186797, "Purified CD34+ Hematopoietic Stem Cell Transplantation From Alternate Donors for Patients With Severe Aplastic Anemia". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00186797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
